Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03020030
Title Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.